Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INCYTE CORPORATION

(INCY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about INCYTE CORPORATION
05/12INCYTE  : Data From Incyte's Oncology Portfolio Accepted for Presentation at the..
BU
05/12INCYTE  : MorphoSys Dose First Patient in Late-Stage Study of Lymphoma Drug Cand..
MT
05/11PRESS RELEASE  : MorphoSys and Incyte Announce -3-
DJ
05/11PRESS RELEASE  : MorphoSys and Incyte Announce -2-
DJ
05/11PRESS RELEASE  : MorphoSys and Incyte Announce First Patient Dosed in Phase 3 fr..
DJ
05/10INCYTE  : Crescendo Biologics Names Incyte VP as Chief Financial Officer
MT
05/05PRESS RELEASE : MorphoSys AG Reports First Quarter -2-
DJ
05/05PRESS RELEASE : MorphoSys AG Reports First Quarter 2021 Results
DJ
05/04INCYTE  : Swings to Q1 Profit, Revenue Rises
MT
05/04INCYTE : Q1 Earnings Snapshot
AQ
05/04INCYTE  : Reports 2021 First Quarter Financial Results and Provides Updates on K..
BU
05/04INCYTE  : Earnings Flash (INCY) INCYTE Reports Q1 EPS $0.67, vs. Street Est of $..
MT
05/03INCYTE  : Announces Data on Ruxolitinib Cream in Atopic Dermatitis Accepted for ..
BU
04/29EMA to quickly review Eli Lilly, Incyte arthritis drug for COVID-19 use
RE
04/27INCYTE  : to Present at Upcoming Investor Conference
BU
04/26ELI LILLY AND  : OLUMIANT Showed Significant Improvements in the Severity and Ex..
AQ
04/23INCYTE  : Announces New Findings from a Randomized Phase 2 Study of Ruxolitinib ..
BU
04/23INCYTE  : Announces New Findings from Pooled Analyses of the Phase 3 TRuE-AD Pro..
BU
04/23DGAP-NEWS : BB BIOTECH AG: Le efficaci campagne di -2-
DJ
04/20MorphoSys and Incyte Announce First Patient Dosed in Phase 3 inMIND Study Eva..
AQ
04/20INCYTE  : Multiple Abstracts from Incyte's Dermatology Portfolio Accepted for Pr..
BU
04/20ELI LILLY, INCYTE : Baricitinib Improves Hair Regrowth in Alopecia Areata
DJ
04/19INCYTE  : MorphoSys, Incyte Begin Late-Stage Study of Chemotherapy Combination w..
MT
04/19PRESS RELEASE : MorphoSys and Incyte Announce -2-
DJ
04/19PRESS RELEASE : MorphoSys and Incyte Announce First Patient Dosed in Phase 3 inM..
DJ
04/19INCYTE  : Credit Suisse Adjusts Incyte's Price Target to $95 from $97, Keeps Neu..
MT
04/13INCYTE  : to Report First Quarter Financial Results
BU
04/08INCYTE  : Eli Lilly's arthritis drug fails to prevent mechanical ventilation in ..
RE
04/08ELI LILLY AND  : Lilly, Incyte COVID-19 Drug Fails To Meet Primary Endpoint
MT
04/08INCYTE  : Eli Lilly's arthritis drug fails to meet main goal of late-stage COVID..
RE
04/08Lilly, Incyte Phase 3 Study of Covid-19 Drug Didn't Meet Primary Endpoint
DJ
04/06ELI LILLY AND  : Incyte Say FDA Extends Review of Dermatitis Drug
MT
04/06INCYTE  : Lilly and Incyte communicate review extension of supplemental New Drug..
PR
04/05INCYTE  : Morgan Stanley Adjusts Price Target on Incyte to $86 From $93, Maintai..
MT
04/01INCYTE  : INCY) sees Significant Insider Selling Continuing
MT
03/31INSIDER TRENDS : 90-Day Insider Buying Trend Reduced with Disposition of Incyte ..
MT
03/31BRIACELL THERAPEUTICS  : to Present at the American Association for Cancer Resea..
AQ
03/30INCYTE  : Pemazyre® approved for adult patients with cholangiocarcinoma in Europ..
AQ
03/29INCYTE  : Receives European Commission Approval for Pemazyre
MT
03/29INCYTE  : Announces the European Commission Approval of Pemazyre® (pemigatinib) ..
BU
03/23INCYTE  : Gets Japanese Regulator's Nod for Treatment Targeting Biliary Tract Ca..
MT
03/23INCYTE  : Announces Approval of Pemazyre® (pemigatinib) in Japan for the Treatme..
BU
03/18INCYTE  : Ruxolitinib Trial in COVID-19 Patients Shows Improvement in Mortality,..
MT
03/18INCYTE  : Announces Results from the Phase 3 DEVENT Study Evaluating Ruxolitinib..
BU
03/15PRESS RELEASE : MorphoSys AG Presents Results for -2-
DJ
03/15PRESS RELEASE : MorphoSys AG Presents Results for Full Year 2020
DJ
03/11INCYTE  : Announces Data from Multiple Programs Within its Oncology Portfolio Ac..
BU
03/04ELI LILLY AND COMPANY  : - Baricitinib is First JAK-Inhibitor to Demonstrate Hai..
AQ
03/03ELI LILLY AND  : Incyte Say Baricitinib Meets Phase 3 Efficacy Endpoint in Treat..
MT
03/03INCYTE, ELI LILLY  : Baricitinib Meets Main Endpoint in Alopecia Areata Study
DJ
02/26INCYTE  : Anal Cancer Drug Receives EMA Validation
MT
02/26INCYTE  : Announces the Validation by the European Medicines Agency of its Marke..
BU
02/24INCYTE  : Annual Call for Submissions Open for the Incyte Ingenuity Award Progra..
PU
02/22INCYTE  : Says FDA Grants Priority Review to Supplemental New Drug Application f..
MT
02/22INCYTE  : Announces Acceptance and Priority Review of sNDA for Jakafi® (ruxoliti..
BU
02/19INCYTE  : New-Drug Application for Ruxolitinib Cream for Atopic Dermatitis Accep..
MT
02/19INCYTE  : Announces Acceptance and Priority Review of NDA for Ruxolitinib Cream ..
BU
02/11MACROGENICS  : Receives $10 Million Milestone Payment From Incyte Under Retifanl..
MT
02/11INCYTE  : to Present at Upcoming Investor Conference
BU
02/10INCYTE  : Morgan Stanley Adjusts Incyte's Price Target to $93 From $97, Keeps Eq..
MT
02/10INCYTE  : SVB Leerink Downgrades Incyte to Underperform From Market Perform; Pri..
MT
02/10INCYTE  : RBC Capital Adjusts Incyte's Price Target to $93 From $89, Maintains S..
MT
02/09INCYTE  : Fourth-Quarter Earnings Handily Beat Street Estimates on Strong Sales ..
MT
02/09INCYTE  : Q4 Adjusted Earnings, Revenue Rise
MT
02/09INCYTE : 4Q Earnings Snapshot
AQ
02/09INCYTE  : Reports 2020 Fourth Quarter and Year-End Financial Results, Provides 2..
BU
02/09INCYTE  : Earnings Flash (INCY) INCYTE Reports Q4 EPS $0.93, vs. Street Est of $..
MT
01/29INCYTE  : Wins Positive EMA Panel Opinion for Pemigatinib for Cholangiocarcinoma..
MT
01/29INCYTE  : Announces Positive CHMP Opinion for Pemigatinib for the Treatment of A..
BU
01/27INSIDER TRENDS : Incyte Sees 90 Days of Insider Buying Trend Scaling Back with S..
MT
01/22PRESS RELEASE : BB BIOTECH AG: Vaccines leading -2-
DJ
01/21INCYTE  : Study of Squamous Cell Carcinoma of Anal Canal Accepted for Priority R..
MT
01/21INCYTE  : Announces Acceptance and Priority Review of BLA for Retifanlimab as a ..
BU
01/19INCYTE  : to Report Fourth Quarter and Year-End 2020 Financial Results
BU
01/13BRIACELL THERAPEUTICS  : Announces Presentation at the 2021 Keystone Symposia Co..
AQ
1  2  3  4  5  6  7  8  9  10Next
Official Publications
05/04Press Release 
05/041st quarter results 
05/04SEC Filing 10Q-1 
05/04SEC Filing 8K 
04/23Report 
04/09Report 
Upcoming event on INCYTE CORPORATION
05/26/21